Vivo Capital, LLC Geron Corp Transaction History
Vivo Capital, LLC
- $472 Million
- Q2 2025
A detailed history of Vivo Capital, LLC transactions in Geron Corp stock. As of the latest transaction made, Vivo Capital, LLC holds 27,225,292 shares of GERN stock, worth $36.8 Million. This represents 8.13% of its overall portfolio holdings.
Number of Shares
27,225,292
Previous 27,225,292
-0.0%
Holding current value
$36.8 Million
Previous $43.3 Million
11.32%
% of portfolio
8.13%
Previous 11.75%
Shares
5 transactions
Others Institutions Holding GERN
# of Institutions
281Shares Held
509MCall Options Held
885KPut Options Held
564K-
Ra Capital Management, L.P. Boston, MA60.4MShares$81.5 Million1.86% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$62.8 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT43MShares$58.1 Million2.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA35.6MShares$48.1 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY23.8MShares$32.1 Million1.76% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $510M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...